Denosumab as Second-Line Treatment in Patients With Metastatic Breast Cancer: A Retrospective Descriptive Pilot Study From a Single Institution

Introduction Bone metastasis in breast cancer patients can lead to poor quality of life and cause significant morbidity. First-line treatments for bone metastases include bone modifying agents that inhibit osteoclast activity to reduce bone resorption. The most commonly used bone modifying agents in...

Полное описание

Библиографические подробности

Главные авторы:	Briana To, Laura E. Wright, Dureti Doto, Julie Stephans, Marilly Palettas, Kai C. Johnson, Mathew Cherian, Daniel Stover, Ashley Davenport, Margaret Gatti-Mays, Robert Wesolowski, Dionisia Quiroga, Sagar Sardesai, Gilbert Bader, Bhuvaneswari Ramaswamy, Nicole Williams
Формат:	Artigo
Язык:	Inglês
Опубликовано:	SAGE Publishing 2026-05-01
Серии:	Cancer Control
Online-ссылка:	https://doi.org/10.1177/10732748261427825
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!